Leonardo Drs, Inc. · NASDAQ:DRS
Leonardo Drs — Q1 2026 Earnings Presentation
8 slides from Leonardo Drs's earnings presentation, May 5, 2026
Slide 1: Quarterly Earnings Presentation Q1 2026
Quarterly Earnings Presentation Q1 | 2026 May 5, 2026
Slide 2: Disclaimers
Disclaimers Forward-Looking Statements In this presentation, when using the terms the “company,” “DRS,” “we,” “us” and “our,” unless otherwise indicated or the context otherwise requires, we are referring to Leonardo DRS, Inc. This presentation contains forward-looking statements and cautionary stat
Slide 3: Key Messages
Key Messages Excellent start to 2026 with strong execution driving growth and profit expansion • Healthy customer demand continues to materialize throughout the portfolio − Q1 2026 marks the 17th consecutive quarter of a book-to-bill ratio at or above 1.0x, providing enhanced visibility 1 and suppor
Slide 4: Q1 2026 Leonardo DRS Results Summary
Q1 2026 Leonardo DRS Results Summary Revenue Adjusted EBITDA * Adjusted Net Earnings * (Dollars in millions) (Dollars in millions) (Dollars in millions) $846 $69 $799 ▲ 6% $105 $54 ▲ 28% $82 ▲ 28% Higher operational Tactical radars, infrared Adjusted EBITDA growth profitability and lower sensing and
Slide 5: Q1 2026 Segment Results Summary
Q1 2026 Segment Results Summary Revenue Segment Adjusted EBITDA * Segment Adjusted EBITDA Margin * (Dollars in millions) (Dollars in millions) Advanced Sensing and Computing (ASC) $559 $62 11.1% $511 ▲ 9% ▲ 48% 8.2% ▲ 290 bps $42 Adjusted EBITDA growth Margin expansion came Growth driven by tactical
Slide 6: Raising 2026 Guidance Across Key Metrics
Raising 2026 Guidance Across Key Metrics Driving Healthy Organic Revenue and Adjusted EBITDA Margin Expansion (In millions, except per share amounts) • Strong backlog-driven visibility into revenue range • Timing and level of material receipts and labor execution Revenue progress remain the primary
Slide 7: Non-GAAP Financial Measures
Non-GAAP Financial Measures Definitions and Reconciliations (Dollars in millions) Three Months Ended March 31, In addition to the results reported in accordance with U.S. GAAP included throughout this 2025 2026 presentation, the company has provided information regarding “Adjusted EBITDA,” “Adjusted
Slide 8: Non-GAAP Financial Measures (Continued)
Non-GAAP Financial Measures (Continued) Definitions and Reconciliations (In millions, except per share amounts) Three Months Ended March 31, Adjusted Net Earnings and Adjusted Diluted EPS are defined as net earnings 2025 2026 excluding amortization of acquired intangible assets, deal-related transac